Suzhou Ribo Life Science Co. Ltd.

This is the first study testing a new drug called RBD1119 in humans. Researchers will give increasing doses to 32 healthy volunteers to check if it's safe and how the body processes it. The main goal is to see what side effects occur and how the drug affects blood clotting pathwa…